Chainguard targets open-core programs, GitHub Actions, and agent skills. The approach starts with its new AI-powered Chainguard Factory 2.0. The company is launching new safety-first programmer ...
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how business process outsourcing & consulting stocks fared in Q4 ...
In March 2026, Rapport Therapeutics granted Tenacia Biotechnology exclusive rights to develop and commercialize its clinical-stage epilepsy and bipolar candidate RAP-219 across Greater China, in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results